---

• South San Francisco, CA
• NASDAQ: CBIO


• Contact:
  Jeff Himawan
  

Related News

• Catalyst Biosciences Completes Merger with Targacept
• Catalyst Biosciences Announces Positive Results From a Phase I Clinical Trial
• Targacept and Catalyst Biosciences Enter Definitive Merger Agreement
• Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
• Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
• Catalyst Biosciences Announces Agreement with MedImmune to Develop Engineered Protease Therapeutics
• Catalyst Biosciences and Wyeth Pharmaceuticals Announce Worldwide Collaboration
• Catalyst Biosciences Raises $40M in Series C Financing